Statistics by Country for HTLV-1
Prevalance of HTLV-1:
About extrapolations of prevalence and incidence statistics for HTLV-1:
WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries.
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of HTLV-1 are typically based on US, UK, Canadian or Australian prevalence or incidence statistics,
which are then extrapolated using only the population of the other country.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated HTLV-1 statistics below refer to.
The extrapolation does not use data sources or statistics about any country other than its population.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of HTLV-1 in that region.
These statistics are presented only in the hope that they may be interesting to some people.
About prevalence and incidence statistics in general for HTLV-1:
The word 'prevalence' of HTLV-1 usually means the estimated population
of people who are managing HTLV-1 at any given time (i.e. people with HTLV-1).
The term 'incidence' of HTLV-1 means the annual diagnosis rate,
or the number of new cases of HTLV-1 diagnosed each year (i.e. getting HTLV-1).
Hence, these two statistics types can differ:
a short disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.